Showing 20 of 75 recruiting trials for “squamous-cell-carcinoma-of-the-larynx”
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
👨⚕️ Matin Imanguli, JHU Sidney Kimmel Comprehensive Cancer Center LAO📍 3 sites📅 Started Aug 2026View details ↗
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma
👨⚕️ yuecan zeng, doctor, The Second Affiliated Hospital of Hainan Medical University📍 1 site📅 Started Feb 2026View details ↗
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
👨⚕️ Jiang D Sui, Ph.D, M.D., Chongqing University Cancer Hospital📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07376603 ↗
IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
RecruitingNCT07232680 ↗
Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy
👨⚕️ Rodney Cheng En Hsieh, MD, PhD, Chang Gung Memorial Hospital📍 1 site📅 Started Nov 2025View details ↗
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
RecruitingNCT06831357 ↗
Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.
Page 1 of 4Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →